Cardinal Health业绩超预期，On大跌，英特尔募资200亿

[music] Bloomberg Audio Studios. Podcasts, radio, news,

the Stock Movers Report, [music] your roundup of companies making moves in the stock market, harnessing the power of Bloomberg data. Let's take a look at some stocks [music] on the move today. I'm Nathan Hager joined by Bloomberg's Dan Curtis leading with the new this morning because we got some fresh earnings crossing the Bloomberg [music] terminal from Cardinal Health. Fill us in. Good morning, Dan. Morning, Nathan.

Shares of Cardinal Health are up 3% in the pre-market under ticker C A. That's as the company sees 20 27 adjusted earnings of $12.40 up to $12.60, even the lower end of that, beating the estimates that were at $126. So, they have a pretty strong outlook for the uh coming fiscal year. They see pharma especially unit uh revenue growth of 3 to 5% and the global medical products unit revenue growth they're seeing that around 2 to 4%.

That's after fiscal fourth quarter. Adjusted earnings came in well a well well above estimates $2.91 basically 50 cents more than they than the Wall Street was expecting. Revenue a little soft 63.7 billion a slight miss there but this outlook helping to lift the stock in the pre-market.

Okay we also got earnings from on holdings. We know the shoes are are pretty hot for uh sneaker fans, but the earnings seem to have left investors pretty cold this morning.

Yeah, they are pretty hot. And the shares are down 16% in the pre-market and that's with uh the Swiss sneaker company posting net sales of 850 million Swiss Franks. That's just over $1 billion. That missed estimates. Company also softened its fullear sales forecast targeting low 20% growth. That was more bearish than previous guidance of 23% or higher. On has been holding us off discounting some older shoe models despite being in the middle of launching new versions of the shoes.

Other brands have been marking down shoes to pull in customers particularly in the US. Um coco David Almond said that strong direct to consumer sales channels are one reason they're they're resisted dropping price and the vision is to become the most premium global sports brand.

Okay. So there's a lot happening as well uh not just in earnings but in the tech space. We know that Intel put out that uh pretty big share sale announcement. Uh seems like it was pretty wellreceived but uh how's the stock doing this morning?

Very wellreceived. So the share is down about 1%. Uh that's as the company upsized its share issuance to $20 billion. Yesterday they said it was going to be $15 billion and then there they according to you know people familiar with the matter it was hundred billion in demand. So they added an extra $5 billion onto that $20 billion. The offerings price at $95 a share. That's only a $6.5% discount to Friday, which is pretty tight for such a volatile stock.

It shows strong demand for in the space and this is with Alphabet in the process of raising $85 billion through an equity sale and Oracle planning to raise 20 billion.

Okay, so a little bit of a dip for uh Intel shares this morning, but the uh biggest gainer in the pre-market this morning, Riot Platforms. Yeah. So, Riot ticker riot is up 18% in the pre-market. This was a biotech company. It turned into a Bitcoin miner and that sir changed again and now it's a data center provider. It's in it inked a $9 billion uh deal with Anthropic. Uh Riot didn't name a specific company, but people familiar uh identified Anthropic as the buyer.

So, this is a 20-year deal to supply 191 megawatts of capacity. That's enough to power 143,000 homes. And there's an option to extend the deal which could result in sales of up to $16 billion. Company also posted two Q numbers with the revenue beating. That really helping the shares this morning.

Okay. Uh you can close this out with uh what's going on with Rocket Lab.

Yeah. So RKLB Rocket Labs down 6% in the pre-market. There's a potential delay with its Neutron rocket. This is a rocket that is designed to challenge SpaceX's Falcon 9, and it was expected to launch in the fourth quarter of this year. The company said it'll be delivered to the launch pad in the fourth quarter, but stopped short of saying it would fly this year. That leaves investors questioning if the rocket will launch before next year, which had been the company's goal.

The exact timing will depend on the outcome of testing for boosters and some other factors according to the company. Company also reported an adjusted loss share of 8 cents. So [music] that was a penny wider than estimated. The Stock Movers Report from Bloomberg Radio. Check back [music] with us throughout the day for the latest roundup of companies making news on Wall Street. [music] And for the latest market moving headlines, listen to Bloomberg Radio Live.

Catch us on YouTube, Bloomberg.com, and on Apple CarPlay and Android Auto with the Bloomberg Business [music] App.